Ubiquitination is a major modulator for the activation of inflammasomes and pyroptosis

被引:8
|
作者
Jiang, Qiuyun [1 ,2 ]
Zhu, Zhigang [3 ]
Mao, Xinliang [1 ,2 ,4 ]
机构
[1] Guangzhou Med Univ, Affiliated Hosp 2, Guangzhou Inst Cardiovasc Dis, Guangdong Key Lab Vasc Dis, Guangzhou 510260, Guangdong, Peoples R China
[2] Guangzhou Med Univ, Sch Basic Med Sci, Guangdong Prov Key Lab Prot Modificat & Degradat, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China
[3] South China Univ Technol, Guangzhou Peoples Hosp 1, Coll Med, Div Hematol & Oncol,Dept Geriatr, Guangzhou 510180, Guangdong, Peoples R China
[4] Guangzhou Med Univ, Sch Basic Med Sci, Guangdong Key Lab Prot Modificat & Degradat, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Inflammasome; Pyroptosis; Ubiquitination; Gasdermin; NF-KAPPA-B; NLRP3; INFLAMMASOME; GASDERMIN D; CELL-DEATH; A20; IFI16; DEGRADATION; MECHANISM; CASPASES; FAMILY;
D O I
10.1016/j.bbagrm.2023.194955
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inflammasomes are a central node of the innate immune defense system against the threat of homeostatic perturbance caused by pathogenic organisms or host-derived molecules. Inflammasomes are generally composed of multimeric protein complexes that assemble in the cytosol after sensing danger signals. Activated inflammasomes promote downstream proteolytic activation, which triggers the release of pro-inflammatory cytokines therefore inducing pyroptotic cell death. The inflammasome pathway is finely tuned by various mechanisms. Recent studies found that protein post-translational modifications such as ubiquitination also modulate inflammasome activation. Targeting the ubiquitination modification of the inflammasome pathway might be a promising strategy for related diseases. In this review, we extensively discuss the advances in inflammasome activation and pyroptosis modulated by ubiquitination which help in-depth understanding and controlling the inflammasome and pyroptosis in various diseases.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Activation and manipulation of inflammasomes and pyroptosis during bacterial infections
    Bernard, Elliott M.
    Broz, Petr
    BIOCHEMICAL JOURNAL, 2022, 479 (07) : 867 - 882
  • [2] Regulation of inflammasomes by ubiquitination
    Bednash, Joseph S.
    Mallampalli, Rama K.
    CELLULAR & MOLECULAR IMMUNOLOGY, 2016, 13 (06) : 722 - 728
  • [3] Uromodulin, Inflammasomes, and Pyroptosis
    Dolores Sanchez-Nino, Maria
    Sanz, Ana B.
    Ortiz, Alberto
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (11): : 1761 - 1763
  • [4] Regulation of inflammasomes by ubiquitination
    Joseph S Bednash
    Rama K Mallampalli
    Cellular & Molecular Immunology, 2016, 13 : 722 - 728
  • [5] Pyroptosis and inflammasomes in cancer and inflammation
    Wang, Jie-Lin
    Hua, Sheng-Ni
    Bao, Hai-Juan
    Yuan, Jing
    Zhao, Yang
    Chen, Shuo
    MEDCOMM, 2023, 4 (05):
  • [6] cGAS-STING, inflammasomes and pyroptosis: an overview of crosstalk mechanism of activation and regulation
    Jingwen Liu
    Jing Zhou
    Yuling Luan
    Xiaoying Li
    Xiangrui Meng
    Wenhao Liao
    Jianyuan Tang
    Zheilei Wang
    Cell Communication and Signaling, 22
  • [7] cGAS-STING, inflammasomes and pyroptosis: an overview of crosstalk mechanism of activation and regulation
    Liu, Jingwen
    Zhou, Jing
    Luan, Yuling
    Li, Xiaoying
    Meng, Xiangrui
    Liao, Wenhao
    Tang, Jianyuan
    Wang, Zheilei
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [8] Emerging Activators and Regulators of Inflammasomes and Pyroptosis
    Xue, Yansong
    Tuipulotu, Daniel Enosi
    Tan, Wei Hong
    Kay, Callum
    Man, Si Ming
    TRENDS IN IMMUNOLOGY, 2019, 40 (11) : 1035 - 1052
  • [9] Pyroptosis and inflammasomes in diabetic wound healing
    Mu, Xingrui
    Wu, Xingqian
    He, Wenjie
    Liu, Ye
    Wu, Faming
    Nie, Xuqiang
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [10] Pyroptosis and inflammasomes in obstetrical and gynecological diseases
    Yu, Shu-Yue
    Li, Xue-Lian
    GYNECOLOGICAL ENDOCRINOLOGY, 2021, 37 (05) : 385 - 391